Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
- DOI
- 10.1017/ash.2023.435
- Published
- 2023
- Container
- Antimicrobial Stewardship & Healthcare Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1017/ash.2023.435,
title = {Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection},
author = {Abigail C. Geyer and Kali M. VanLangen and Andrew P. Jameson and Lisa E. Dumkow},
year = {2023},
journal = {Antimicrobial Stewardship \& Healthcare Epidemiology},
doi = {10.1017/ash.2023.435},
url = {https://doi.org/10.1017/ash.2023.435}
}RIS
TY - JOUR TI - Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection AU - Abigail C. Geyer AU - Kali M. VanLangen AU - Andrew P. Jameson AU - Lisa E. Dumkow PY - 2023 JO - Antimicrobial Stewardship & Healthcare Epidemiology DO - 10.1017/ash.2023.435 UR - https://doi.org/10.1017/ash.2023.435 ER -
APA
Geyer, A. C., VanLangen, K. M., Jameson, A. P., & Dumkow, L. E. (2023). Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection. Antimicrobial Stewardship & Healthcare Epidemiology. https://doi.org/10.1017/ash.2023.435
Source records
- crossref · retrieved 2026-09-25T14:48:44.617Z